Efficacy That Begins with Tolerability Trademark Details

Efficacy That Begins with Tolerability was registered on Tuesday, May 4, 2004 and is currently owned by Glaxosmithkline LLC under the registration number 2839183 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 13 years ago on Friday, December 10, 2010, according to the United State Patent & Trademark Office
Word Mark Efficacy That Begins with Tolerability
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation
Serial Number 78118356
Registration Number 2839183
Status Date Friday, December 10, 2010
Filing Date Friday, December 10, 2010
Registration Date Tuesday, May 4, 2004
Attorney Maribeth Day Case
Domestic Representative Maribeth Day Case

Correspondent

Maribeth Day Case
GlaxoSmithKline
Five Moore Drive
LGTM, C.3157.3D
Research Triangle Park NC 27709

Case File Statements

Goods & Services Printed Materials Relating to the Treatment and Diagnosis of Depression and Other Central Nervous System Disorders

Classifications

International Class Codes
016 — Class 16 includes mainly paper, goods made from that material and office requisites.
U.S. Class Codes 002, 005, 022, 023, 029, 037, 038, 050
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, December 10, 2010
First Use Anywhere Saturday, August 31, 2002
First Use In Commerce Saturday, August 31, 2002
Primary Code 016

You must be signed in to print.

Once signed in, look for the PDF button.